Axcelis Technologies Inc: Form 10-Q for the period ended Sep 30, 2019
Filed with the SEC on Nov 7, 2019 and accepted by EDGAR at Nov 7, 2019, 10:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-30 | $69.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-01-01 to 2019-09-30 | $235.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-07-01 to 2019-09-30 | $38.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-30 | $135.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-07-01 to 2019-09-30 | $30.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-01-01 to 2019-09-30 | $99.8m | us-gaap:GrossProfit |
| Research and development | 3 months2019-07-01 to 2019-09-30 | $12.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-01-01 to 2019-09-30 | $40.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-07-01 to 2019-09-30 | $1.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-30 | $11.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-07-01 to 2019-09-30 | $1.3m | us-gaap:InterestExpense |
| Interest expense | 9 months2019-01-01 to 2019-09-30 | $3.8m | us-gaap:InterestExpense |
| Income tax | 3 months2019-07-01 to 2019-09-30 | −$328.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-30 | $943.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-30 | $704.0k | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months2019-01-01 to 2019-09-30 | $7.3m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2019-07-01 to 2019-09-30 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-30 | $0.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-07-01 to 2019-09-30 | $0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-30 | $0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-07-01 to 2019-09-30 | 33,323,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-30 | 33,821,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-30 | −$345.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-01-01 to 2019-09-30 | $11.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2019-01-01 to 2019-09-30 | $14.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-09-30 | $155.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-30 | $353.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-30 | $530.5m | us-gaap:Assets |
| Current liabilities | At period end2019-09-30 | $63.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-09-30 | $122.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-09-30 | $407.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-19-010306. Last ingested by Listed: Nov 13, 2026, 17:24 ET. Listed shows no prices and gives no investment advice.